Skip Navigation


Nucleic Acids Research Advance Access originally published online on April 16, 2007
Nucleic Acids Research 2007 35(9):2955-2964; doi:10.1093/nar/gkm181
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1835K) Freely available
Right arrow Screen PDF (297K) Freely available
Right arrowOA All Versions of this Article:
35/9/2955    most recent
gkm181v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kinomoto, M.
Right arrow Articles by Tokunaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinomoto, M.
Right arrow Articles by Tokunaga, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2007, Vol. 35, No. 9 2955-2964
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Molecular Biology

All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

Masanobu Kinomoto1, Takayuki Kanno1, Mari Shimura2, Yukihito Ishizaka2, Asato Kojima1, Takeshi Kurata1, Tetsutaro Sata1 and Kenzo Tokunaga1,*

1Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan and 2Department of Intractable Diseases, International Medical Center of Japan, Tokyo, 162-8655, Japan

*To whom correspondence should be addressed. Tel: +81 3 5285 1111; Fax: +81 3 5285 1189; Email: tokunaga{at}nih.go.jp

Received January 29, 2007. Revised February 25, 2007. Accepted March 13, 2007.

Approximately 17% of the human genome is comprised of long interspersed nuclear element 1 (LINE-1, L1) non-LTR retrotransposons. L1 retrotransposition is known to be the cause of several genetic diseases, such as hemophilia A, Duchene muscular dystrophy, and so on. The L1 retroelements are also able to cause colon cancer, suggesting that L1 transposition could occur not only in germ cells, but also in somatic cells if innate immunity would not function appropriately. The mechanisms of L1 transposition restriction in the normal cells, however, are not fully defined. We here show that antiretroviral innate proteins, human APOBEC3 (hA3) family members, from hA3A to hA3H, differentially reduce the level of L1 retrotransposition that does not correlate either with antiviral activity against Vif-deficient HIV-1 and murine leukemia virus, or with patterns of subcellular localization. Importantly, hA3G protein inhibits L1 retrotransposition, in striking contrast to the recent reports. Inhibitory effect of hA3 family members on L1 transposition might not be due to deaminase activity, but due to novel mechanism(s). Thus, we conclude that all hA3 proteins act to differentially suppress uncontrolled transposition of L1 elements.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
S. Gallois-Montbrun, R. K. Holmes, C. M. Swanson, M. Fernandez-Ocana, H. L. Byers, M. A. Ward, and M. H. Malim
Comparison of Cellular Ribonucleoprotein Complexes Associated with the APOBEC3F and APOBEC3G Antiviral Proteins
J. Virol., June 1, 2008; 82(11): 5636 - 5642.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J.-P. Vartanian, D. Guetard, M. Henry, and S. Wain-Hobson
Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions
Science, April 11, 2008; 320(5873): 230 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Bennett, V. Presnyak, J. E. Wedekind, and H. C. Smith
Nuclear Exclusion of the HIV-1 Host Defense Factor APOBEC3G Requires a Novel Cytoplasmic Retention Signal and Is Not Dependent on RNA Binding
J. Biol. Chem., March 21, 2008; 283(12): 7320 - 7327.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. J. Schumacher, G. Hache, D. A. MacDuff, W. L. Brown, and R. S. Harris
The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 Restriction
J. Virol., March 15, 2008; 82(6): 2652 - 2660.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. R. Muotri, M. C.N. Marchetto, N. G. Coufal, and F. H. Gage
The necessary junk: new functions for transposable elements
Hum. Mol. Genet., October 15, 2007; 16(R2): R159 - R167.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.